These inconsistencies might be due to an insufficient coverage of mutations within the SMAD4 gene in the panel; further technical improvement of the gene panel, which covers sufficient hot spot mutations of the SMAD4 gene, would increase the detection accuracy in patients with pancreatic cancer. This evidence concerns the gene SMAD4 and familial pancreatic carcinoma.